The clinical nutrition for cancer care market size has grown strongly in recent years. It will grow from $5.16 billion in 2025 to $5.42 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing incidence of cancer cases, expansion of oncology treatment centers, rising awareness of nutrition in cancer outcomes, growth in clinical nutrition programs, availability of specialized oncology nutrition products.
The clinical nutrition for cancer care market size is expected to see steady growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing focus on personalized oncology care, rising demand for high-protein and immune-support nutrition, expansion of outpatient cancer treatment models, growing adoption of digital nutrition monitoring tools, increasing emphasis on quality-of-life improvement during cancer therapy. Major trends in the forecast period include increasing adoption of personalized nutrition plans for cancer patients, rising use of specialized enteral and parenteral formulations, growing integration of nutritional monitoring technologies, expansion of home-based clinical nutrition support, enhanced focus on symptom-specific nutritional interventions.
The increasing prevalence of cancer is expected to drive the growth of the clinical nutrition for cancer care market in the coming years. Cancer is a group of diseases characterized by uncontrolled cell growth with the potential to spread to other parts of the body. The rise in cancer cases is largely associated with longer life expectancy, which results in a growing aging population that is more susceptible to cancer. Clinical nutrition for cancer care provides specialized dietary management and nutritional support tailored to the specific needs of cancer patients, with the objective of improving treatment tolerance and optimizing clinical outcomes. For instance, in February 2024, according to the World Health Organization, a US-based intergovernmental organization, approximately 35 million new cancer cases are projected worldwide by 2050, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the clinical nutrition for cancer care market.
Major companies operating in the clinical nutrition for cancer care market are increasingly focusing on data-driven approaches and advanced genomic profiling to support personalized cancer care, improve treatment effectiveness, and enable patient-specific therapy selection. Advanced genomic profiling involves comprehensive analysis of a patient’s genetic information to identify mutations and biomarkers that guide individualized cancer diagnosis, treatment planning, and prognosis. For example, in December 2024, Aster DM Healthcare, a UAE-based healthcare provider, launched Precision Oncology, a platform designed to deliver personalized cancer care through genomic analysis, biomarker identification, and data-driven treatment recommendations. This initiative aims to support tailored therapy strategies, enhance clinical decision-making, and improve overall patient outcomes by integrating advanced diagnostics with precision medicine approaches.
In January 2024, Danone S.A., a France-based food products company, partnered with Resilience to develop an integrated nutrition and oncology module within Resilience’s digital oncology platform. This partnership is intended to improve nutritional care for cancer patients by addressing cancer-related malnutrition, which affects a significant proportion of individuals undergoing cancer treatment. Resilience is a US-based digital oncology company that provides clinical nutrition support and digital care solutions for cancer patients.
Major companies operating in the clinical nutrition for cancer care market are Abbott Nutrition, Baxter International Inc., B Braun Melsungen AG, Nestle Health Science S A, Danone Nutricia, Hormel Health Labs, Evonik Industries AG, Otsuka Holdings Co Ltd, Koninklijke DSM N V, Glanbia plc, Meiji Holdings Company Ltd, Victus Inc., Global Health Products Inc., Fresenius Kabi AG, Perrigo Company plc, Arla Foods Ingredients Group P S, Kerry Group plc, Lonza Group AG, Ajinomoto Co Inc., Yakult Honsha Co Ltd, Rousselot BV, Tate Lyle plc, ADM Human Nutrition, Vitaflo International Ltd, Smartfish AS, Medtrition Inc.
North America was the largest region in the clinical nutrition for cancer care market in 2025. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clinical nutrition for cancer care market by increasing costs of imported raw ingredients, specialized nutrients, packaging materials, and formulation equipment used in oral, enteral, and parenteral nutrition products. Healthcare providers and nutrition suppliers in North America and Europe are most affected due to reliance on imported clinical-grade ingredients, while Asia-Pacific faces higher costs in specialized nutrition manufacturing. These tariffs are raising product prices and affecting procurement budgets. However, they are also encouraging local ingredient sourcing, domestic formulation capabilities, and regional production of clinical nutrition solutions.
The clinical nutrition for cancer care market research report is one of a series of new reports that provides clinical nutrition for cancer care market statistics, including clinical nutrition for cancer care industry global market size, regional shares, competitors with a clinical nutrition for cancer care market share, detailed clinical nutrition for cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for cancer care industry. This clinical nutrition for cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical nutrition for cancer care involves specialized dietary support and nutritional interventions designed to address the unique nutritional needs of individuals with cancer throughout their treatment journey. This approach focuses on delivering personalized nutrition plans that help manage treatment-related symptoms, support therapy effectiveness, and enhance overall quality of life for patients undergoing cancer care.
The primary types of clinical nutrition for cancer care include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition involves the consumption of food and fluids by mouth to provide essential nutrients and is particularly important for supporting patients receiving cancer treatment. These nutritional solutions are used across various cancer types such as head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and others, and cater to both adult and pediatric age groups. Clinical nutrition for cancer care products are distributed through sales channels including online platforms, retail outlets, and institutional sales.
The clinical nutrition for cancer care market consists of sales of clinical nutrition products such as high-protein supplements and dietary supplements rich in antioxidants, vitamins, and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The clinical nutrition for cancer care market size is expected to see steady growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing focus on personalized oncology care, rising demand for high-protein and immune-support nutrition, expansion of outpatient cancer treatment models, growing adoption of digital nutrition monitoring tools, increasing emphasis on quality-of-life improvement during cancer therapy. Major trends in the forecast period include increasing adoption of personalized nutrition plans for cancer patients, rising use of specialized enteral and parenteral formulations, growing integration of nutritional monitoring technologies, expansion of home-based clinical nutrition support, enhanced focus on symptom-specific nutritional interventions.
The increasing prevalence of cancer is expected to drive the growth of the clinical nutrition for cancer care market in the coming years. Cancer is a group of diseases characterized by uncontrolled cell growth with the potential to spread to other parts of the body. The rise in cancer cases is largely associated with longer life expectancy, which results in a growing aging population that is more susceptible to cancer. Clinical nutrition for cancer care provides specialized dietary management and nutritional support tailored to the specific needs of cancer patients, with the objective of improving treatment tolerance and optimizing clinical outcomes. For instance, in February 2024, according to the World Health Organization, a US-based intergovernmental organization, approximately 35 million new cancer cases are projected worldwide by 2050, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the clinical nutrition for cancer care market.
Major companies operating in the clinical nutrition for cancer care market are increasingly focusing on data-driven approaches and advanced genomic profiling to support personalized cancer care, improve treatment effectiveness, and enable patient-specific therapy selection. Advanced genomic profiling involves comprehensive analysis of a patient’s genetic information to identify mutations and biomarkers that guide individualized cancer diagnosis, treatment planning, and prognosis. For example, in December 2024, Aster DM Healthcare, a UAE-based healthcare provider, launched Precision Oncology, a platform designed to deliver personalized cancer care through genomic analysis, biomarker identification, and data-driven treatment recommendations. This initiative aims to support tailored therapy strategies, enhance clinical decision-making, and improve overall patient outcomes by integrating advanced diagnostics with precision medicine approaches.
In January 2024, Danone S.A., a France-based food products company, partnered with Resilience to develop an integrated nutrition and oncology module within Resilience’s digital oncology platform. This partnership is intended to improve nutritional care for cancer patients by addressing cancer-related malnutrition, which affects a significant proportion of individuals undergoing cancer treatment. Resilience is a US-based digital oncology company that provides clinical nutrition support and digital care solutions for cancer patients.
Major companies operating in the clinical nutrition for cancer care market are Abbott Nutrition, Baxter International Inc., B Braun Melsungen AG, Nestle Health Science S A, Danone Nutricia, Hormel Health Labs, Evonik Industries AG, Otsuka Holdings Co Ltd, Koninklijke DSM N V, Glanbia plc, Meiji Holdings Company Ltd, Victus Inc., Global Health Products Inc., Fresenius Kabi AG, Perrigo Company plc, Arla Foods Ingredients Group P S, Kerry Group plc, Lonza Group AG, Ajinomoto Co Inc., Yakult Honsha Co Ltd, Rousselot BV, Tate Lyle plc, ADM Human Nutrition, Vitaflo International Ltd, Smartfish AS, Medtrition Inc.
North America was the largest region in the clinical nutrition for cancer care market in 2025. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the clinical nutrition for cancer care market by increasing costs of imported raw ingredients, specialized nutrients, packaging materials, and formulation equipment used in oral, enteral, and parenteral nutrition products. Healthcare providers and nutrition suppliers in North America and Europe are most affected due to reliance on imported clinical-grade ingredients, while Asia-Pacific faces higher costs in specialized nutrition manufacturing. These tariffs are raising product prices and affecting procurement budgets. However, they are also encouraging local ingredient sourcing, domestic formulation capabilities, and regional production of clinical nutrition solutions.
The clinical nutrition for cancer care market research report is one of a series of new reports that provides clinical nutrition for cancer care market statistics, including clinical nutrition for cancer care industry global market size, regional shares, competitors with a clinical nutrition for cancer care market share, detailed clinical nutrition for cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for cancer care industry. This clinical nutrition for cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Clinical nutrition for cancer care involves specialized dietary support and nutritional interventions designed to address the unique nutritional needs of individuals with cancer throughout their treatment journey. This approach focuses on delivering personalized nutrition plans that help manage treatment-related symptoms, support therapy effectiveness, and enhance overall quality of life for patients undergoing cancer care.
The primary types of clinical nutrition for cancer care include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition involves the consumption of food and fluids by mouth to provide essential nutrients and is particularly important for supporting patients receiving cancer treatment. These nutritional solutions are used across various cancer types such as head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and others, and cater to both adult and pediatric age groups. Clinical nutrition for cancer care products are distributed through sales channels including online platforms, retail outlets, and institutional sales.
The clinical nutrition for cancer care market consists of sales of clinical nutrition products such as high-protein supplements and dietary supplements rich in antioxidants, vitamins, and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Clinical Nutrition for Cancer Care Market Characteristics
3. Clinical Nutrition for Cancer Care Market Supply Chain Analysis
4. Global Clinical Nutrition for Cancer Care Market Trends and Strategies
5. Clinical Nutrition for Cancer Care Market Analysis of End Use Industries
7. Global Clinical Nutrition for Cancer Care Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Clinical Nutrition for Cancer Care Total Addressable Market (TAM) Analysis for the Market
9. Clinical Nutrition for Cancer Care Market Segmentation
10. Clinical Nutrition for Cancer Care Market Regional and Country Analysis
11. Asia-Pacific Clinical Nutrition for Cancer Care Market
12. China Clinical Nutrition for Cancer Care Market
13. India Clinical Nutrition for Cancer Care Market
14. Japan Clinical Nutrition for Cancer Care Market
15. Australia Clinical Nutrition for Cancer Care Market
16. Indonesia Clinical Nutrition for Cancer Care Market
17. South Korea Clinical Nutrition for Cancer Care Market
18. Taiwan Clinical Nutrition for Cancer Care Market
19. South East Asia Clinical Nutrition for Cancer Care Market
20. Western Europe Clinical Nutrition for Cancer Care Market
21. UK Clinical Nutrition for Cancer Care Market
22. Germany Clinical Nutrition for Cancer Care Market
23. France Clinical Nutrition for Cancer Care Market
24. Italy Clinical Nutrition for Cancer Care Market
25. Spain Clinical Nutrition for Cancer Care Market
26. Eastern Europe Clinical Nutrition for Cancer Care Market
27. Russia Clinical Nutrition for Cancer Care Market
28. North America Clinical Nutrition for Cancer Care Market
29. USA Clinical Nutrition for Cancer Care Market
30. Canada Clinical Nutrition for Cancer Care Market
31. South America Clinical Nutrition for Cancer Care Market
32. Brazil Clinical Nutrition for Cancer Care Market
33. Middle East Clinical Nutrition for Cancer Care Market
34. Africa Clinical Nutrition for Cancer Care Market
36. Clinical Nutrition for Cancer Care Market Competitive Landscape and Company Profiles
37. Clinical Nutrition for Cancer Care Market Other Major and Innovative Companies
40. Clinical Nutrition for Cancer Care Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Clinical Nutrition For Cancer Care Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses clinical nutrition for cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clinical nutrition for cancer care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical nutrition for cancer care market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Oral Nutrition; Parenteral Nutrition; Enteral Feeding Formulas2) By Cancer Type: Head And Neck Cancer; Stomach And Gastrointestinal Cancers; Blood Cancer; Breast Cancer; Lung Cancer; Other Cancer Types
3) By Age Group: Adult; Pediatric
4) By Sales Channel: Online; Retail; Institutional Sales
Subsegments:
1) By Oral Nutrition: Protein-Rich Supplements; Carbohydrate-Rich Supplements; Fat-Rich Supplements; Vitamins And Mineral Supplements; Caloric Supplements; Fiber-Enriched Supplements2) By Parenteral Nutrition: Amino Acids; Carbohydrates; Lipids; Electrolytes And Micronutrients; Intravenous Fat Emulsions; Trace Elements And Vitamins
3) By Enteral Feeding Formulas: Standard Enteral Feeding Formulas; High-Protein Enteral Formulas; High-Calorie Enteral Formulas; Diabetic Enteral Formulas; Elemental Enteral Formulas; Specialized Enteral Formulas
Companies Mentioned: Abbott Nutrition; Baxter International Inc.; B Braun Melsungen AG; Nestle Health Science S A; Danone Nutricia; Hormel Health Labs; Evonik Industries AG; Otsuka Holdings Co Ltd; Koninklijke DSM N V; Glanbia plc; Meiji Holdings Company Ltd; Victus Inc.; Global Health Products Inc.; Fresenius Kabi AG; Perrigo Company plc; Arla Foods Ingredients Group P S; Kerry Group plc; Lonza Group AG; Ajinomoto Co Inc.; Yakult Honsha Co Ltd; Rousselot BV; Tate Lyle plc; ADM Human Nutrition; Vitaflo International Ltd; Smartfish AS; Medtrition Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Clinical Nutrition for Cancer Care market report include:- Abbott Nutrition
- Baxter International Inc.
- B Braun Melsungen AG
- Nestle Health Science S A
- Danone Nutricia
- Hormel Health Labs
- Evonik Industries AG
- Otsuka Holdings Co Ltd
- Koninklijke DSM N V
- Glanbia plc
- Meiji Holdings Company Ltd
- Victus Inc.
- Global Health Products Inc.
- Fresenius Kabi AG
- Perrigo Company plc
- Arla Foods Ingredients Group P S
- Kerry Group plc
- Lonza Group AG
- Ajinomoto Co Inc.
- Yakult Honsha Co Ltd
- Rousselot BV
- Tate Lyle plc
- ADM Human Nutrition
- Vitaflo International Ltd
- Smartfish AS
- Medtrition Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.42 Billion |
| Forecasted Market Value ( USD | $ 6.5 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
